Evidence map›Paper›PMID 39220559›Full record

ArticleThe Pan African medical journal2024

Evaluation of Gallium-68 prostate-specific membrane antigen, positron emission tomography/computed tomography (GA-68 PSMA PET/CT) in recurrent prostate cancer: a retrospective review of initial clinical experience at Tygerberg Hospital.

Bright Awadh Sangiwa, Celeste Burger, Annare Ellmann

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bright Awadh SangiwaDepartment of Nuclear Medicine, Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa.
Celeste BurgerDepartment of Nuclear Medicine, Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa.
Annare EllmannDepartment of Nuclear Medicine, Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: prostate cancer recurrence after definitive therapy for organ-confined disease often manifests as rising prostate-specific antigen (PSA) levels without clinically overt disease. Methods: a retrospective analysis of 177 Results: a total of 177 Conclusion: there was an increase in the detection rate with an increase in the PSA. Gleason score was not a predictor of a positive

Indexed as

Gallium IsotopesGallium RadioisotopesNeoplasm GradingNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyProstate-Specific AntigenProstatic NeoplasmsAgedAged, 80 and overEdetic AcidHumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesProstate-Specific AntigenRadiopharmaceuticals68Ga PSMA PET/CTProstate cancerTygerberg Hospital

Identifiers

PMID39220559
PMCPMC11364939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.